Zealand Pharma A/S (CPH:ZEAL)
211.40
-1.30 (-0.61%)
Nov 20, 2026, 11:00 AM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 14.13 billion as of November 19, 2026. It is the 6,132nd most valuable company in the world and the 33rd biggest in Denmark. Its market cap has decreased by 60.66% in one year.
Market Cap
14.13B
Enterprise Value
1.10B
Revenue
4.60B
Global Rank
Country Rank
#33 Denmark
PE Ratio
4.83
ChartMarket Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 14.13B, an increase of 905.13%. That is a compound annual growth rate of 15.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 14.13B | -56.99% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.20T |
| Genmab | 221.28B |
| Coloplast | 113.08B |
| Demant | 72.72B |
| ALK-Abelló | 53.92B |
| Ambu A/S | 23.25B |
| Bavarian Nordic | 18.13B |
| GN Store Nord | 17.20B |